V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310003005 | 310001279 | 1.78 | 94 | Palliative (P) | 2015-08-13 | 2015-09-02 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 310016921 | CISPLATIN + GEMCITABINE |
| 310003006 | 310008980 | 1.63 | null | Curative (C) | 2016-04-11 | 2016-04-11 | Trial Unspecified | 01 | N | 310016929 | TRIAL |
| 310003007 | 310008980 | 1.58 | 59.8 | Palliative (P) | 2015-01-07 | 2015-01-21 | Carboplatin + Etoposide IV 3 day | N | N | 310016929 | CARBOPLATIN + ETOPOSIDE |
| 310003008 | 310001280 | 1.78 | 88.1 | Palliative (P) | 2018-06-08 | 2018-06-10 | Ipilimumab | 02 | null | 310016934 | IPILIMUMAB |
| 310003009 | 310001280 | 1.94 | 79 | null | 2017-01-07 | 2017-01-07 | CHOP R - 21 days | N | N | 310016934 | CHOP R |
| 310003010 | 310001281 | null | 53 | null | 2015-03-30 | 2015-03-30 | Carboplatin + Etoposide iv&po | 02 | null | 310016943 | CARBOPLATIN + ETOPOSIDE |
| 310003012 | 310001283 | 1.75 | 14.5 | null | 2013-10-06 | 2013-10-11 | Ipilimumab | 2 | N | 310016946 | IPILIMUMAB |
| 310003013 | 310006508 | 1.75 | null | Palliative (P) | 2013-03-01 | 2013-03-02 | PEMBROLIZUMAB | N | N | 310016949 | PEMBROLIZUMAB |
| 310003014 | 310006508 | 1.77 | 105.6 | Palliative (P) | 2017-11-14 | 2017-11-24 | Ipilimumab | 2 | N | 310016949 | IPILIMUMAB |
| 310003015 | 310001284 | null | 4.3 | Palliative (P) | 2017-04-13 | 2017-04-14 | Doxorubicin 75mg/m2 | 2 | N | 310016953 | DOXORUBICIN |
| 310003016 | 310001285 | 1.88 | 121.5 | Palliative (P) | 2016-08-31 | 2016-09-25 | Carboplatin + Etoposide iv&po | N | N | 310016958 | CARBOPLATIN + ETOPOSIDE |
| 310003017 | 310001285 | 1.66 | 69 | Palliative (P) | 2015-09-26 | 2015-10-07 | DOXORUBICIN | 2 | N | 310016958 | DOXORUBICIN |
| 310003018 | 310008982 | 1.61 | 57 | Palliative (P) | 2015-11-13 | 2015-11-21 | DOXORUBICIN | N | N | 310016961 | DOXORUBICIN |
| 310003019 | 310008982 | null | 13.8 | null | 2017-09-20 | 2017-09-21 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | 310016961 | CISPLATIN + GEMCITABINE |
| 310003020 | 310001286 | 1.7 | 75.1 | Curative (C) | null | 2017-05-18 | Cisplatin | N | Y | 310016970 | CISPLATIN |
| 310003021 | 310001287 | 1.54 | 74 | Curative (C) | 2017-07-11 | 2017-08-01 | CHOP R - 21 days | N | N | 310016971 | CHOP R |
| 310003022 | 310001287 | 1.6 | 64.9 | Curative (C) | 2017-05-27 | 2017-06-02 | CHOP R - 21 days | N | N | 310016971 | CHOP R |
| 310003023 | 310001288 | 1.6 | null | Palliative (P) | 2016-03-18 | 2016-04-13 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | 310016975 | CISPLATIN + GEMCITABINE |
| 310003024 | 310001288 | 1.58 | 104 | Adjuvant (A) | 2013-04-29 | 2013-05-06 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 310016975 | CISPLATIN + GEMCITABINE |
| 310003025 | 310001288 | 1.7 | 17.8 | Curative (C) | 2013-05-22 | 2013-06-20 | Cisplatin | N | Y | 310016975 | CISPLATIN |
| 310003026 | 310001289 | 1.88 | 97.6 | Palliative (P) | 2014-08-17 | 2014-08-27 | Carboplatin + Etoposide IV 3 day | N | N | 310016986 | CARBOPLATIN + ETOPOSIDE |
| 310003027 | 310001290 | null | 80 | Palliative (P) | 2017-01-26 | 2017-02-07 | Ipilimumab | N | N | 310016992 | IPILIMUMAB |
| 310003028 | 310006512 | 1.78 | 52.1 | Palliative (P) | 2016-06-24 | 2016-07-13 | Ipilimumab | N | N | 310016993 | IPILIMUMAB |
| 310003029 | 310008984 | 1.78 | 99.8 | Palliative (P) | 2017-01-07 | 2017-01-08 | Ipilimumab | 02 | N | 310016994 | IPILIMUMAB |
| 310003030 | 310008984 | 1.71 | 57.7 | Palliative (P) | 2017-02-05 | 2017-02-08 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 310016994 | CISPLATIN + GEMCITABINE |
| 310003031 | 310001291 | null | null | Curative (C) | 2016-05-04 | 2016-05-19 | Cisplatin 7 day | N | Y | 310017000 | CISPLATIN |
| 310003032 | 310001292 | null | 54 | null | 2016-12-16 | 2016-12-30 | Cisplatin | N | Y | 310017009 | CISPLATIN |
| 310003033 | 310001293 | null | 54 | Palliative (P) | 2015-09-16 | 2015-09-22 | DOXORUBICIN | 02 | null | 310017017 | DOXORUBICIN |
| 310003034 | 310001293 | 1.62 | 54.5 | Palliative (P) | 2014-03-06 | 2014-03-06 | PEMBROLIZUMAB | 02 | N | 310017017 | PEMBROLIZUMAB |
| 310003035 | 310001293 | null | 7 | Curative (C) | 2015-05-18 | 2015-05-18 | CHOP R - 21 days | 2 | N | 310017017 | CHOP R |
| 310003036 | 310001294 | null | 66 | Palliative (P) | 2015-08-06 | 2015-08-06 | PEMBROLIZUMAB | N | N | 310017023 | PEMBROLIZUMAB |
| 310003037 | 310001295 | 1.66 | 76 | Palliative (P) | 2016-03-29 | 2016-04-13 | PEMBROLIZUMAB | N | N | 310017024 | PEMBROLIZUMAB |
| 310003038 | 310001295 | 1.76 | 70 | Palliative (P) | 2017-05-23 | 2017-05-23 | PEMBROLIZUMAB | 02 | N | 310017024 | PEMBROLIZUMAB |
| 310003044 | 310001298 | 0 | 73.6 | Curative (C) | 2016-01-29 | 2016-02-03 | Retinoblastoma JOE | N | N | 310017058 | CEV |
| 310003045 | 310001298 | 0 | 94 | Adjuvant (A) | 2017-06-23 | 2017-07-15 | Retinoblastoma JOE | N | N | 310017058 | CEV |
| 310003046 | 310001299 | 1.74 | 62 | Palliative (P) | 2016-07-17 | 2016-07-20 | CISPLATIN + GEMCITABINE | N | N | 310017068 | CISPLATIN + GEMCITABINE |
| 310003047 | 310001300 | null | 53.9 | Curative (C) | 2014-01-11 | 2014-02-23 | Retinoblastoma JOE | N | N | 310017070 | CEV |
| 310003048 | 310006518 | 1.9 | 92 | Palliative (P) | 2016-06-02 | 2016-06-03 | Trial Unspecified | N | null | 310017072 | TRIAL |
| 310003049 | 310006518 | null | 48.8 | Palliative (P) | 2018-02-18 | 2018-02-23 | PEMBROLIZUMAB | N | N | 310017072 | PEMBROLIZUMAB |
| 310003050 | 310001301 | null | 84.5 | Palliative (P) | 2015-10-18 | 2015-10-21 | PEMBROLIZUMAB | 02 | N | 310017078 | PEMBROLIZUMAB |
| 310003051 | 310006519 | 1.59 | 56 | Palliative (P) | null | 2015-02-19 | CISPLATIN + GEMCITABINE | N | null | 310017080 | CISPLATIN + GEMCITABINE |
| 310003052 | 310006519 | 1.7 | 100 | null | 2017-01-16 | 2017-01-17 | EW EuroEwing 2012 Arm B IE | 01 | null | 310017080 | TRIAL |
| 310003053 | 310010294 | 1.52 | 14.5 | Palliative (P) | 2013-09-04 | 2013-09-04 | Trial Unspecified | null | N | 310017082 | TRIAL |
| 310003054 | 310010294 | 1.57 | 82 | Curative (C) | 2017-11-05 | 2017-11-27 | Cisplatin | 02 | Y | 310017082 | CISPLATIN |
| 310003055 | 310010294 | null | null | Palliative (P) | 2014-10-01 | 2014-10-05 | Ipilimumab | null | N | 310017082 | IPILIMUMAB |
| 310003056 | 310011652 | null | 89 | Curative (C) | 2013-05-09 | 2013-05-11 | Retinoblastoma JOE | null | N | 310017102 | CEV |
| 310003057 | 310001302 | 1.86 | 15 | Palliative (P) | 2015-03-17 | 2015-03-19 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310017103 | CISPLATIN + GEMCITABINE |
| 310003058 | 310001302 | 1.51 | 67 | Palliative (P) | 2014-02-20 | 2014-03-09 | CISPLATIN + GEMCITABINE | N | N | 310017103 | CISPLATIN + GEMCITABINE |
| 310003059 | 310001302 | 1.63 | 55 | Curative (C) | 2017-08-09 | 2017-08-25 | CHOP R - 21 days | 02 | N | 310017103 | CHOP R |
| 310003061 | 310001304 | 1.63 | 67.999 | Palliative (P) | 2015-07-08 | 2015-07-18 | Carboplatin + Etoposide iv&po | 02 | N | 310017134 | CARBOPLATIN + ETOPOSIDE |